Why Aduhelm Still Faces Alzheimer’s Hurdles & Disappointment Despite FDA Approval
Alzheimer’s Disease was supposed to get a new opponent after Biogen Inc. received unexpected...
Home » Diseases & Conditions » Neurology » Alzheimer's
by Kendra Evans | Sep 1, 2021 | Aduhelm (aducanumab), Alzheimer's, Diseases & Conditions, Drugs, Neurology
Alzheimer’s Disease was supposed to get a new opponent after Biogen Inc. received unexpected...
by Kendra Evans | Apr 27, 2021 | Alzheimer's, CA, Diseases & Conditions, Drugs, Neurology
by Kendra Evans | Jan 12, 2021 | Alzheimer's, Diseases & Conditions, donanemad, Drugs, Neurology
by Kendra Evans | Jan 12, 2021 | Alzheimer's, Diseases & Conditions, donanemad, Drugs, Neurology | 0
A positive Phase 2 trial brings hope to millions of people suffering from Alzheimer’s...
Read Moreby Kendra Evans | Mar 23, 2021 | Alzheimer's, Diseases & Conditions, Drugs, Neurology, Semaglutide | 0 |
It seems almost impossible to accept that Alzheimer’s Disease and related memory loss and...
Read Moreby Kendra Evans | Apr 27, 2021 | Alzheimer's, CA, Diseases & Conditions, Drugs, Neurology | 0 |
The race to find a cure or treatment in the battle against Alzheimer’s Disease has to date...
Read Moreby Kendra Evans | Jun 11, 2021 | Aduhelm (aducanumab), Alzheimer's, Diseases & Conditions, Drugs, Neurology | 0 |
The FDA grants accelerated approval for Aduhelm (aducanumab), the first-of-its-kind treatment...
Read Moreby Kendra Evans | Sep 1, 2021 | Aduhelm (aducanumab), Alzheimer's, Diseases & Conditions, Drugs, Neurology | 0 |
Alzheimer’s Disease was supposed to get a new opponent after Biogen Inc. received unexpected...
Read More